MSB 2.10% $1.17 mesoblast limited

Ann: Change of Director's Interest Notice - Silviu Itescu, page-105

  1. 30,317 Posts.
    lightbulb Created with Sketch. 1836

    I find it interesting that while the FDA is acknowledging it needs reform, and even engaged in it currently,
    your entire focus is on Silviu Itescu.

    Not EVER on what the FDA has got wrong.

    There is a lot of case law to show that it's got things wrong in the past. Badly wrong.

    So if it's being subject to review and admissions made, then...

    Why would the mistakes/deficiencies/incompetence/conflicts of interest of the FDA not ever be your focus?

    Your assumptions are all wrong my friend but I guess when you're paid to take a certain view, then that outcome is sure to be consistent.

    The barrage continues.

    (Of course I only criticise people's their morals or lack of,
    capabilities or lack of when claiming authority
    when they have none).
    Last edited by dolcevita: 13/12/23
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.17
Change
-0.025(2.10%)
Mkt cap ! $1.330B
Open High Low Value Volume
$1.18 $1.22 $1.15 $6.344M 5.404M

Buyers (Bids)

No. Vol. Price($)
1 8683 $1.16
 

Sellers (Offers)

Price($) Vol. No.
$1.17 32999 1
View Market Depth
Last trade - 16.10pm 15/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.